Elligo Health Research, an integrated research organization (IRO), accelerates the development of new pharmaceutical, biotechnology, medical device, and diagnostic products using our novel IntElligo Research Stack™ clinical technology and our Goes Direct® approach. We unite the best clinical experts with the best research infrastructure - creating the ultimate clinical trial solution. It is our mission to ensure that all patients have access to clinical trials as a care option by maintaining the integrity of the trusted patient and physician relationship, and building global communities of research leveraging electronic health records. In doing so, we expand the base of physicians and their patients who otherwise would not participate in clinical trials.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
05/07/19	$20,000,000	Series C	Piper Jaffray Merchant Banking	undisclosed
09/23/21	$135,000,000	Series E	Ally Bridge Group Cerner Capital Hatteras Venture Partners Morgan Stanley Noro-Moseley Partners Norwest Venture Partners Piper Sandler Merchant Banking Shumway Capital Syneos Health	undisclosed